Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model

Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model

As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial assessment of candidate vaccines, with subsequent deployment as part of mass vaccination campaigns. However, the SARS-CoV-2 virus has demonstrated the ability to mutate and develop variants, which can...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Gog, JR, Hill, EM, Danon, L, Thompson, RN
Format:	Journal article
Język:	English
Wydane:	Royal Society 2021

Podobne zapisy

Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
od: Julia R. Gog, i wsp.
Wydane: (2021-07-01)

Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design
od: Varun Jaiswal, i wsp.
Wydane: (2022-04-01)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
od: Chiranjib Chakraborty, i wsp.
Wydane: (2022-02-01)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
od: Danyi Ao, i wsp.
Wydane: (2022-03-01)

Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies
od: James S. Koopman, i wsp.
Wydane: (2021-09-01)

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
od: Nur Zawanah Zabidi, i wsp.
Wydane: (2023-04-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
od: Kim, KS, i wsp.
Wydane: (2021)

SARS-CoV-2 Exposure in Escaped Mink, Utah, USA
od: Susan A. Shriner, i wsp.
Wydane: (2021-03-01)

Estimation of heterogeneous instantaneous reproduction numbers with application to characterize SARS-CoV-2 transmission in Massachusetts counties
od: Zhou, Z, i wsp.
Wydane: (2022)

An Evolutionary Insight Into the Heterogeneous Severity Pattern of the SARS-CoV-2 Infection
od: Rabail Zehra Raza, i wsp.
Wydane: (2022-03-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
od: Florian D. Hastert, i wsp.
Wydane: (2022-05-01)

The probability of detection of SARS-CoV-2 in saliva
od: Thompson, RN, i wsp.
Wydane: (2020)

Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape
od: Rochman, Nash D, i wsp.
Wydane: (2023)

Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape
od: Nash D. Rochman, i wsp.
Wydane: (2022-04-01)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
od: Marianne Graninger, i wsp.
Wydane: (2022-05-01)

Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: a modelling study.
od: Leng, T, i wsp.
Wydane: (2022)

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
od: Syed Mohammed Basheeruddin Asdaq, i wsp.
Wydane: (2022-01-01)

Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
od: Mohammad Shah Alam
Wydane: (2023-02-01)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
od: Ragonnet-Cronin, M, i wsp.
Wydane: (2023)

A Review of the Genetic Diversity and Immune Escape of SARS-CoV-2
od: K Mobarki Dil, i wsp.
Wydane: (2022-08-01)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
od: Manon Ragonnet-Cronin, i wsp.
Wydane: (2023-06-01)

Multi-task learning for predicting SARS-CoV-2 antibody escape
od: Barak Gross, i wsp.
Wydane: (2022-08-01)

A Review of the Genetic Diversity and Immune Escape of SARS-CoV-2
od: K Mobarki Dil, i wsp.
Wydane: (2022-08-01)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
od: Ranjeet Singh Mahla, i wsp.
Wydane: (2022-02-01)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
od: Li Zhang, i wsp.
Wydane: (2022-12-01)

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
od: Zhou, D, i wsp.
Wydane: (2021)

A novel approach to finding conserved features in low-variability gene alignments characterises RNA motifs in SARS-CoV and SARS-CoV-2
od: Jordan P. Skittrall, i wsp.
Wydane: (2023-07-01)

Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools
od: Leng, T, i wsp.
Wydane: (2022)

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
od: Tuekprakhon, A, i wsp.
Wydane: (2022)

A Systematic Review of Genetically Challenging Changes of SARS-CoV-2 Variants; Escaping the Immune System and Vaccine Effectiveness
od: Javad Sarvmeili
Wydane: (2022-08-01)

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation
od: Xinyue Chang, i wsp.
Wydane: (2023-02-01)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
od: Xun Wang, i wsp.
Wydane: (2022-12-01)

An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants
od: Miller, Nathaniel L., i wsp.
Wydane: (2021)

Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population
od: Eva Bednarski, i wsp.
Wydane: (2022-08-01)

Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population
od: Fabrice Carrat, i wsp.
Wydane: (2022-05-01)

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
od: Khadija Khan, i wsp.
Wydane: (2023-12-01)

An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants
od: Nathaniel L. Miller, i wsp.
Wydane: (2021-10-01)

Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike.
od: Xiaodi Yu, i wsp.
Wydane: (2023-05-01)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
od: Leander Witte, i wsp.
Wydane: (2023-01-01)

CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
od: Arnaud John Kombe Kombe, i wsp.
Wydane: (2022-10-01)